share_log
Reuters ·  May 3 06:01
Amneal Pharmaceuticals Inc: Q1 2024 Net Revenue of $659 Mln; Gaap Net Loss of $92 Mln; Diluted Loss per Share of $0.30
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment